home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Full Day Virtual Webinar: Medical Device Process Validation - FDA Inspectors are Checking – Are You Prepared?

 
  November 08, 2012  
     
 
ComplianceOnline, Online Event
2012-11-15


Why Should You Attend:

In your manufacturing processes, how can you be sure the output is right if you don’t check every piece? Many manufacturers face this problem, but don’t always have a good solution. The FDA expects you to answer it using process validation. Using the Quality System Inspection Technique (QSIT) the Inspector will ask for process validation procedures and the results for your product. Product, as defined by QSR includes components, in-process devices, and finished devices.

Do you know which processes in your firm require process validation? Can you provide objective evidence that you evaluated each process and documented the decision?

With the FDA looking closely, can you show how the product requirements moved from design through Design Transfer to Production? Can you show that you validated and monitor the production processes? The lack of procedures and data can lead straight to 483s, warning letters, and even product seizures.

Learning Objectives:

Sign up your entire team and get a clear understanding of the requirements and methods for process validation, including:

  • Understanding what “a high degree of assurance” means in statistical terms.
  • The three step approach employing Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
  • Developing protocols and reports for IQ, OQ, and PQ.
  • What information to include in the protocols and reports.
  • How to use the link the IQ Protocol to OSHA requirements to enhance your total regulatory compliance.
  • The basics of Statistical Process Control (SPC) to help monitor the validated process.
  • The role of Design of Experiments (DOE) to help define acceptable process parameters and develop challenge points.
  • Using attribute sampling plans in process verification.
  • The FDA Guidance document on process validation and the current status from the CDRH view.
  • The Global Harmonization Task Force (GHTF) document on process validation.

Who Will Benefit:

  • Process validation starts with design controls and moves to manufacturing through design transfer
    • Design Engineers
    • Design Technicians
  • Production sets and monitors the process parameters to make the product
    • Quality Engineers
    • Production Engineers
    • Production Managers and Supervisors
    • Production Operators
  • The production equipment must be installed, maintained, and calibrated
    • Plant Engineering
    • Maintenance Managers and Supervisors
  • Validated process contribute to Risk Management
    • Compliance Officers
    • Risk Managers
    • Regulatory affairs professionals

 

 
 
Organized by: Complianceonline
Invited Speakers:

Daniel O'Leary, has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics, focusing on logic and number theory. His professional experience relates to quality, reliability, and operations management. Dan is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence. Ombu helps companies achieve efficient and effective processes and regulatory compliance.

 

 
Deadline for Abstracts: 2012-11-14
 
Registration:

 
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.